These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38482405)

  • 21. Predictive value of the monocyte-to-lymphocyte ratio in the diagnosis of prostate cancer.
    Xu Z; Zhang J; Zhong Y; Mai Y; Huang D; Wei W; Huang J; Zhao P; Lin F; Jin J
    Medicine (Baltimore); 2021 Sep; 100(38):e27244. PubMed ID: 34559125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.
    Caster JM; Falchook AD; Hendrix LH; Chen RC
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):244-51. PubMed ID: 25841621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor.
    Vives Dilme R; Rivas JG; Fernández Hernández L; De la Parra Sánchez I; Sánchez Del Hoyo R; Galante Romo MI; Redondo González E; Senovilla Pérez JL; Fernández Montarroso L; Moreno Sierra J
    Ther Adv Urol; 2024; 16():17562872241229250. PubMed ID: 38333072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Total PSA, PSA density and biopsy Gleason score in predicting the pathologic stage of prostate cancer].
    Liu S; Lü JJ; Fu Q; Zhang H; Gao DX; Liu Z
    Zhonghua Nan Ke Xue; 2010 May; 16(5):415-9. PubMed ID: 20684321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
    Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y
    Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.
    Palisaar RJ; Graefen M; Karakiewicz PI; Hammerer PG; Huland E; Haese A; Fernandez S; Erbersdobler A; Henke RP; Huland H
    Eur Urol; 2002 Feb; 41(2):155-61. PubMed ID: 12074402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators.
    Liu X; Zhang Y; Duan H; Yang L; Sheng C; Fan Z; Liu Y; Gao Y; Wang X; Zhang Q; Lyu Z; Song F; Song F; Huang Y
    Eur J Med Res; 2023 Jul; 28(1):257. PubMed ID: 37496058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models.
    Chen M; Ma T; Li J; Zhang HJ; Li Q; Wang JJ; Sang T; Cao CL; Cui XW
    Med Sci Monit; 2021 Feb; 27():e929913. PubMed ID: 33556045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer.
    Nepal SP; Nakasato T; Fukagai T; Ogawa Y; Nakagami Y; Shichijo T; Morita J; Maeda Y; Oshinomi K; Unoki T; Noguchi T; Inoue T; Kato R; Amano S; Mizunuma M; Kurokawa M; Tsunokawa Y; Yasuda S
    Asian J Urol; 2023 Apr; 10(2):158-165. PubMed ID: 36942115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Inflammatory Response in Predicting Prostate Cancer: The Diagnostic Value of Neutrophil-To-Lymphocyte Ratio.
    Adhyatma KP; Prapiska FF; Siregar GP; Warli SM
    Open Access Maced J Med Sci; 2019 May; 7(10):1628-1630. PubMed ID: 31210812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
    Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of PI-RADS v2 scores combined with prostate specific antigen in diagnosis of peripheral zone prostate cancer: a logistic regression analysis].
    Lei LZ; Xu YK; Hou MR; He MQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Aug; 37(8):1092-1097. PubMed ID: 28801291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer.
    Zhang JY; Ge P; Zhang PY; Zhao M; Ren L
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical research analysis based on prostate cancer screening diagnosis.
    Shan J; Geng X; Liu Z; Lu Y; Zhou R; Zhang Z; Xu H; Zhou X; Ma W; Zhu H; Shi H
    Andrologia; 2022 May; 54(4):e14371. PubMed ID: 35014705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.